Merck

Fierce Pharma

Merck unveils $3B cost-cutting plan

CEO Rob Davis called the restructuring a “multiyear optimization initiative” that will redirect resources from mature franchise to new growth drivers.

Kevin Dunleavy Jul 29, 2025 8:15am

Merck wades deeper into HIV PrEP waters with pair of trials

Jul 14, 2025 1:12pm

Merck's HIV combo treatment meets efficacy bar in phase 3 trials

Dec 19, 2024 11:54am

Historical building and Yale university campus in downtown New Haven CT USA

Amgen, Merck join academic clinical trial diversity partnership

Sep 16, 2024 3:10pm

Male and female superheroes posing in fluttering cloaks

ESMO: Cancer vaccine and Keytruda deliver in phase 2 trial

Sep 14, 2024 2:30am

Graphic of two hands shaking under a red and purple light

Merck to use N-Power clinical trial platform for cancer studies

Jul 1, 2024 4:20pm